The Potential Prognostic Impact of Associated Peritoneal Carcinomatosis in Patients with Stage II and III Epithelial Ovarian Cancer Who Had Upfront Complete Cytoreduction
- 25 March 2024
- journal article
- research article
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 14-17
Abstract
Background The presence of metastatic peritoneal nodules in epithelial ovarian cancer (EOC) is considered a prognostic factor of both overall survival and disease-free survival. The goal of this study is to assess the potential prognostic effect of associated peritoneal carcinomatosis and PCI in stage II and III EOC patients after undergoing complete cytoreduction (CC score 0 or 1). Patients and Methods This is a retrospective cohort study including 50 high-grade serous EOC cases treated and followed up from 2012 and 2016. Twenty-three cases had peritoneal nodules at the time of exploration. PCI was assessed intraoperatively in each case. Twenty-seven cases had no peritoneal nodules (were given PCI 0). Results The presence of peritoneal nodules, presence of ascites, and stage of the disease had statistically significant impact on overall survival, but with multivariate analysis, only presence of peritoneal nodules was associated with a statistically significant reduced overall survival (HR 6.192; 95% CI 1.248–30.720; P value 0.026). The presence of peritoneal nodules was associated with a statistically significant higher incidence of postoperative death (P value 0.038). PCI had no statistically significant impact on overall survival, disease-free survival, or incidence of postoperative death (within 30 days after surgery). Conclusion The presence of peritoneal nodules had a statistically significant impact on overall survival and incidence of postoperative death. There was no statistically significant prognostic impact of PCI in stage II and III EOC patients who had complete cytoreduction.Keywords
This publication has 9 references indexed in Scilit:
- Prognostic impact of initial tumor load and intraperitoneal disease dissemination patterns in patients with advanced ovarian cancer undergoing complete cytoreductive surgeryEuropean Journal of Surgical Oncology, 2019
- Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective studyJournal of Gynecologic Oncology, 2018
- Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy to Treat Advanced/Recurrent Epithelial Ovarian Cancer: Results from a Retrospective Study on Prospectively Established DatabaseTranslational Oncology, 2016
- Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume centerEuropean Journal of Surgical Oncology, 2016
- Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian CancerAnnals of Surgical Oncology, 2015
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Persistent and Recurrent Advanced Ovarian Carcinoma: A Multicenter, Prospective Study of 246 PatientsAnnals of Surgical Oncology, 2012
- Peritoneal carcinomatosis from ovarian epithelial primary: combined aggressive treatment.2009
- Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancerEuropean Journal of Surgical Oncology, 2003
- Prognostic factors in ovarian cancer.1998